News Sep 20, 2023
Porton Gets Improved in the 2023 S&P Global ESG Score
Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)
News Sep 13, 2023
Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization and Drug Product Development Services
Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)
News Aug 29, 2023
Pharma Digital Intelligence Summit will be held on 5th, September, 2023
Join us for a Journey of Innovation at J-STAR Research, Inc.'s Cranbury Open House!
News Aug 09, 2023
J-STAR Research, Inc.'s Cranbury Open House
Join us for a Journey of Innovation at J-STAR Research, Inc.'s Cranbury Open House!
News Jul 28, 2023
[Important Notice] Porton Announcement Regarding the Change of Email Domain
Porton Pharma Solutions Ltd. continues to expand its reach globally. Last year, we launched the construction of a new site in Menges, Slovenia. The state-of-the-art GMP manufacturing site will significantly expand Porton’s network beyond China and the US as it sets out to provide solutions to customers and partners in Europe.
News Jun 23, 2023
Porton Pharma Solutions Launches State-of-the-Art Small Molecule Platform in Shanghai, Elevating CDMO Services
We are thrilled to announce the establishment of our state-of-the-art Small Molecule Platform in Shanghai, revolutionizing our CDMO services. With this exciting development, Porton Pharma Solutions Ltd. now have seven R&D and production facilities in Shanghai that are equipped to provide comprehensive solutions for drug substance, drug preparation, synthetic macromolecules, and biological macromolecules.
News Jun 23, 2023
Porton Pharma Solutions Welcomes Alexandra Pichard Nielsen, VP of Business Development, at BOS Basel 2023, Driving Innovation and Growth in the Pharmaceutical Industry
We’re honored to have Alexandra Pichard Nielsen, Vice President for Business Development at Porton Pharma Solutions Ltd., join us at BOS Basel 2023!
News Jun 23, 2023
[Important Notice] Porton Announcement Regarding the Change of Email Domain
Porton Pharma Solutions Ltd. continues to expand its reach globally. Last year, we launched the construction of a new site in Menges, Slovenia. The state-of-the-art GMP manufacturing site will significantly expand Porton’s network beyond China and the US as it sets out to provide solutions to customers and partners in Europe.
News Jun 23, 2023
Yuriy Abramov, Ph.D., to Present Groundbreaking Insights on Computational Studies of Pharmaceutical Crystals at the 6th David Grand Symposium
Join J-STAR Research, Inc. Executive Director of computational chemistry and datas science, Yuriy Abramov, Ph.D., as he takes the stage as an invited speaker at the 6th David Grand Symposium on June 15. He will share his insights on computational Studies on the crystallization development and characterization of pharmaceutical crystals, and engage in meaningful discussions with fellow experts in the field. Looking forward to connecting, learning, and making new connections at this prestigious event.
